Anisa Nizarali Virani

This inventor holds 15 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Sodium Channel Modulators. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anisa Nizarali Virani. Retrieved from https://idiyas.com/inventor/anisa-nizarali-virani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 11)

% Patents Active = 86.7

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 12.6

ph-index = 6

Forward Citations = 167(Granted Patents)

Location History:

Abingdon, GB (2014)
Thatcham, GB (2013 - 2024)

Company Filing History:

15 out of 1,168

Vertex Pharmaceuticals, Inc.

patents

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Sodium Channels

Tetrahydrofurans

ATR Kinase

Inhibitors

Pyrazines

Carboxamides

Modulators

Pharmaceuticals

Compounds

Substituted

Heteroaryl

Hydroxyalkyl

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662470 - Hydroxy and (halo)alkoxy substituted tetrahydrofurans as modulators of sodium channels (2026-06-23),

2. 12258333 - N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels (2025-03-25),

3. 12247021 - Substituted tetrahydrofurans as modulators of sodium channels (2025-03-11),

4. 11919887 - Substituted tetrahydrofurans as modulators of sodium channels (2024-03-05),

5. 11834441 - Substituted tetrahydrofurans as modulators of sodium channels (2023-12-05),

6. 11827627 - N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels (2023-11-28),

7. 10961232 - Substituted pyrazines as ATR kinase inhibitors (2021-03-30),

8. 10479784 - Substituted pyrazin-2-amines as inhibitors of ATR kinase (2019-11-19),

9. 9701674 - Substituted pyrazines as ATR kinase inhibitors (2017-07-11),

10. 9630956 - Compounds useful as inhibitors of ATR kinase (2017-04-25),

11. 9365557 - Substituted pyrazin-2-amines as inhibitors of ATR kinase (2016-06-14),

12. 9334244 - Compounds useful as inhibitors of ATR kinase (2016-05-10),

13. 9062008 - Compounds useful as inhibitors of ATR kinase (2015-06-23),

14. 8623869 - Compounds useful as inhibitors of ATR kinase (2014-01-07),

15. 8410112 - Compounds useful as inhibitors of ATR kinase (2013-04-02),

As an AI assistant specialized in innovations, inventions, inventors, and patents, I can help you create an article about inventor Anisa Nizarali Virani.

Title: Anisa Nizarali Virani: Pioneering Inventor Shaping the Future of Technology

Introduction:

Anisa Nizarali Virani, a prolific inventor based in Thatcham, GB, is renowned for her unwavering passion for innovation. Her dedication to creating a better world through technology has solidified her legacy as a pioneering figure shaping the future of technology and beyond.

Latest Patents:

With an impressive portfolio of 11 patents, Anisa Nizarali Virani's latest inventions include "Substituted Tetrahydrofurans as Modulators of Sodium Channels" and "N-(Hydroxyalkyl (Hetero)aryl) Tetrahydrofuran Carboxamides as Modulators of Sodium Channels." These compounds and pharmaceutical compositions exhibit significant potential as inhibitors of sodium channels, offering innovative solutions for the treatment of various disorders, particularly pain.

Career Highlights:

Anisa Nizarali Virani is currently associated with Vertex Pharmaceuticals, Inc., a leading company in the field of pharmaceuticals and biotechnology. Her contributions to the company's research and development initiatives have been instrumental in advancing cutting-edge solutions for healthcare challenges.

Collaborations:

Throughout her career, Anisa Nizarali Virani has collaborated with esteemed professionals in the industry, including her coworkers Steven John Durrant and Joanne Louise Pinder. These collaborations have fostered a culture of innovation and knowledge-sharing, further enhancing her impact in the field.

Conclusion:

In conclusion, Anisa Nizarali Virani's remarkable journey as an inventor epitomizes a steadfast commitment to innovation and technological advancement. Her groundbreaking inventions and collaborations underscore her influence in shaping the future of technology, leaving an indelible mark on the world of inventions and patents.

Profile summary based on public USPTO records.